title: CFTR and asthma in the French EGEA study.
authors.forename: R
authors.initials: R
authors.lastname: de Cid
authors.forename: J C
authors.initials: JC
authors.lastname: Chomel
authors.forename: C
authors.initials: C
authors.lastname: Lazaro
authors.forename: J
authors.initials: J
authors.lastname: Sunyer
authors.forename: M
authors.initials: M
authors.lastname: Baudis
authors.forename: T
authors.initials: T
authors.lastname: Casals
authors.forename: N
authors.initials: N
authors.lastname: Le Moual
authors.forename: A
authors.initials: A
authors.lastname: Kitzis
authors.forename: J
authors.initials: J
authors.lastname: Feingold
authors.forename: J
authors.initials: J
authors.lastname: Anto
authors.forename: X
authors.initials: X
authors.lastname: Estivill
authors.forename: F
authors.initials: F
authors.lastname: Kauffmann
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D001249:Asthma / Q000453:epidemiology / Q000235:genetics*; D002648:Child; D019005:Cystic Fibrosis Transmembrane Conductance Regulator / Q000235:genetics*; D005260:Female; D005602:France / Q000453:epidemiology; D005787:Gene Frequency; D006579:Heterozygote; D006801:Humans; D008297:Male; D008875:Middle Aged; D009154:Mutation
chemical_list: C505032:CFTR protein, human; C093349:cystic fibrosis transmembrane conductance regulator delta F508; D019005:Cystic Fibrosis Transmembrane Conductance Regulator